Kristina M. Utzschneider, MD
Associate Professor of Medicine
University of Washington
Seattle, WA
Randy J. Seeley, PhD
Professor of Surgery
University of Michigan
Ann Arbor, MI
Jenny Tong, MD, MPH
Associate Professor of Medicine
Division of Metabolism, Endocrinology and Nutrition
University of Washington
Seattle, WA
STATEMENT OF INDEPENDENCE
As a provider of CME accredited by the Accreditation Council for Continuing Medical Education, the Endocrine Society has a policy of ensuring that the content and quality of this educational activity are balanced, independent, objective, and scientifically rigorous. The scientific content of this activity was developed under the supervision of the Endocrine Society’s guideline task force.
DISCLOSURE POLICY
The faculty, committee members, and staff who are in position to control the content of this activity are required to disclose to the Endocrine Society and to learners any relevant financial relationship(s) of the individual or spouse/partner that have occurred within the last 12 months with any commercial interest(s) whose products or services are related to the content. Financial relationships are defined by remuneration in any amount from the commercial interest(s) in the form of grants; research support; consulting fees; salary; ownership interest (e.g., stocks, stock options, or ownership interest excluding diversified mutual funds); honoraria or other payments for participation in speakers' bureaus, advisory boards, or boards of directors; or other financial benefits. The intent of this disclosure is not to prevent planners with relevant financial relationships from planning or delivery of content, but rather to provide learners with information that allows them to make their own judgments of whether these financial relationships may have influenced the educational activity with regard to exposition or conclusion.
The following faculty reported relevant financial relationships:
Randy J. Seeley, PhD: Consulting Fee, Novo Nordisk, Sanofi-Aventis, Kintai, Scohia, Eli Lilly & Company, Ionis Pharmaceuticals Inc.; Grant Recipient, AstraZeneca, Novo Nordisk, Pfizer Global R&D, Kintai, Energesis; Stock Owner, Zafgen, Calibrate Health, Rewind Health.
The following faculty reported no relevant financial relationships:
Kristina M. Utzschneider, MD, Jenny Tong, MD, MPH
The following SPC member who planned and reviewed content for this activity reported the following financial relationships: Amy E. Rothberg, MD, PhD: Spouse, Consultant of Merck
The following SPC Committee members reported financial relationships:
- Andjela T. Drincic, MD: Advisory Board Member, Corcept
- Sergio Fazio, MD, PhD: Consultant, Amarin, Amgen, Akcea, Aegerion, Esperion, Novartis
- Angela M. Leung, MD: Speaker, Medical Education Resources, MCE Conferences, ATA Board Member
- Katherine Araque, MD: Speaker, Novo Nordisk; Advisory Board, Corcept
The Endocrine Society has reviewed these relationships to determine which are relevant to the content of this activity and resolved any identified conflicts of interest for these individuals.
Disclosure information for presenters is included in their individual recorded presentations.
The following SPC members reported no relevant financial relationships:
Lorena Alarcon-Casas Wright, MD; Beret Casey, MD; Neena Natt, MD; Kelly Lauter Roszko, MD, PhD; Deborah Sellmeyer, MD; Savitha Subramanian, MD; Soleymani Taraneh, MD; Steven Weitzman, MD
The staff involved in the development of this CME activity reported no relevant financial relationships.
The Endocrine Society staff have reviewed all disclosures and resolved or managed all relevant identified conflicts of interest, as applicable.
ACKNOWLEDGMENT OF COMMERCIAL SUPPORT
This educational activity is supported by an independent medical educational grant from Novo Nordisk, Inc.